BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23651172)

  • 1. Human T-lymphotropic virus type 1 non-structural proteins: Requirements for latent infection.
    Fukumoto R
    Cancer Sci; 2013 Aug; 104(8):983-8. PubMed ID: 23651172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the HTLV-1 viral factors in the induction of apoptosis.
    Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B
    Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative virology of HTLV-1 and HTLV-2.
    Martinez MP; Al-Saleem J; Green PL
    Retrovirology; 2019 Aug; 16(1):21. PubMed ID: 31391116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-1: A real pathogen or a runaway guest of a diseased cell?
    Kanzaki LIB
    J Biosci; 2018 Sep; 43(4):785-795. PubMed ID: 30207322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
    Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
    Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of human T-lymphotropic virus type 1 transmission and disease.
    Lairmore MD; Haines R; Anupam R
    Curr Opin Virol; 2012 Aug; 2(4):474-81. PubMed ID: 22819021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients.
    Ramirez E; Fernandez J; Cartier L; Villota C; Rios M
    Virus Res; 2003 Feb; 91(2):231-9. PubMed ID: 12573502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between various biosensor methods for human T-lymphotropic virus-1 (HTLV-1) detection.
    Kamali P; Zandi M; Ghasemzadeh-Moghaddam H; Fani M
    Mol Biol Rep; 2022 Feb; 49(2):1513-1517. PubMed ID: 34797491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research and discovery of the first human cancer virus, HTLV-1.
    Gallo RC
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):559-65. PubMed ID: 22127321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.
    Martinez ARM; Casseb RF; Martins CR; Nucci A; França MC
    J Neurovirol; 2018 Jun; 24(3):369-371. PubMed ID: 29318453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-1 associated myelopathy/tropical spastic paraparesis: how far have we come?
    Morgan O
    West Indian Med J; 2011 Oct; 60(5):505-12. PubMed ID: 22519224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia].
    Matsuoka M
    Rinsho Ketsueki; 2006 Dec; 47(12):1493-501. PubMed ID: 17233467
    [No Abstract]   [Full Text] [Related]  

  • 18. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum.
    Rodgers-Johnson PE
    Mol Neurobiol; 1994; 8(2-3):175-9. PubMed ID: 7999314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.